Hematopoietic Stem Cell Transplantation (HSCT) for Common Variable Immunodeficiency (CVID) and Other Autoimmune Manifestations of Primary Immune Regulatory Disorders (PIRD)

Recruiting

Phase 2

HSCT with TBIHematopoietic Stem Cell Transplantation (HSCT) for Common Variable Immunodeficiency (CVID) and Other Autoimmune Manifestations of Primary Immune Regulatory Disorders (PIRD)

Sponsor:

Paul Szabolcs

Code:

NCT07284641

Conditions

Common Variable Immunodeficiency (CVID)

Primary Immune Regulatory Disorder

Immune Dysregulation

DiGeorge Syndrome

STAT 1 Gain of Function

Eligibility Criteria

Sex: All

Age: 5 - 40

Healthy Volunteers: Not accepted

Interventions

Hematopoietic stem cell transplant (HSCT)

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2026-03-10. This information was provided to ClinicalTrials.gov by Paul Szabolcs on 2026-02-20.